These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 36890070)

  • 1. High lipoprotein(a) levels and mitral valve disease: A systematic review.
    Masson W; Barbagelata L; Oberti P; Falconi M; Lavalle-Cobo A; Corral P; Nogueira JP
    Nutr Metab Cardiovasc Dis; 2023 May; 33(5):925-933. PubMed ID: 36890070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein(a) is a risk factor for aortic and mitral valvular stenosis in peripheral arterial disease.
    Hojo Y; Kumakura H; Kanai H; Iwasaki T; Ichikawa S; Kurabayashi M
    Eur Heart J Cardiovasc Imaging; 2016 May; 17(5):492-7. PubMed ID: 26758409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein(a) and Subclinical Vascular and Valvular Calcification on Cardiac Computed Tomography: The Atherosclerosis Risk in Communities Study.
    Obisesan OH; Kou M; Wang FM; Boakye E; Honda Y; Uddin SMI; Dzaye O; Osei AD; Orimoloye OA; Howard-Claudio CM; Coresh J; Blumenthal RS; Hoogeveen RC; Budoff MJ; Matsushita K; Ballantyne CM; Blaha MJ
    J Am Heart Assoc; 2022 Jun; 11(11):e024870. PubMed ID: 35656990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated lipoprotein(a) in mitral and aortic valve calcification and disease: The Copenhagen General Population Study.
    Kaltoft M; Sigvardsen PE; Afzal S; Langsted A; Fuchs A; Kühl JT; Køber L; Kamstrup PR; Kofoed KF; Nordestgaard BG
    Atherosclerosis; 2022 May; 349():166-174. PubMed ID: 34903381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein(a) and calcific aortic valve stenosis: A systematic review.
    Guddeti RR; Patil S; Ahmed A; Sharma A; Aboeata A; Lavie CJ; Alla VM
    Prog Cardiovasc Dis; 2020; 63(4):496-502. PubMed ID: 32526213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic associations with valvular calcification and aortic stenosis.
    Thanassoulis G; Campbell CY; Owens DS; Smith JG; Smith AV; Peloso GM; Kerr KF; Pechlivanis S; Budoff MJ; Harris TB; Malhotra R; O'Brien KD; Kamstrup PR; Nordestgaard BG; Tybjaerg-Hansen A; Allison MA; Aspelund T; Criqui MH; Heckbert SR; Hwang SJ; Liu Y; Sjogren M; van der Pals J; Kälsch H; Mühleisen TW; Nöthen MM; Cupples LA; Caslake M; Di Angelantonio E; Danesh J; Rotter JI; Sigurdsson S; Wong Q; Erbel R; Kathiresan S; Melander O; Gudnason V; O'Donnell CJ; Post WS;
    N Engl J Med; 2013 Feb; 368(6):503-12. PubMed ID: 23388002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of serum levels of novel atherosclerotic risk factors on aortic valve calcification.
    Bozbas H; Yildirir A; Atar I; Pirat B; Eroglu S; Aydinalp A; Ozin B; Muderrisoglu H
    J Heart Valve Dis; 2007 Jul; 16(4):387-93. PubMed ID: 17702363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein (a) and risk for calcification of the coronary arteries, mitral valve, and thoracic aorta: The Multi-Ethnic Study of Atherosclerosis.
    Garg PK; Guan W; Karger AB; Steffen BT; Budoff M; Tsai MY
    J Cardiovasc Comput Tomogr; 2021; 15(2):154-160. PubMed ID: 32620506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of lipoprotein (a) and LPA KIV2 repeat polymorphism in bicuspid aortic valve stenosis and calcification: a proof of concept study.
    Sticchi E; Giusti B; Cordisco A; Gori AM; Sereni A; Sofi F; Mori F; Colonna S; Fugazzaro MP; Pepe G; Nistri S; Marcucci R
    Intern Emerg Med; 2019 Jan; 14(1):45-50. PubMed ID: 30099661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in associated factors between aortic and mitral valve calcification in hemodialysis.
    Ikee R; Honda K; Ishioka K; Oka M; Maesato K; Moriya H; Hidaka S; Ohtake T; Kobayashi S
    Hypertens Res; 2010 Jun; 33(6):622-6. PubMed ID: 20379193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of serum lipoprotein(a) in elderly patients with aortic valve sclerosis].
    Suzuki S; Sato K; Taniguchi M; Miyagawa K; Kojima M; Dohi Y; Ueda R
    Nihon Ronen Igakkai Zasshi; 1998 Jun; 35(6):444-50. PubMed ID: 9745298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Lipoprotein (a) variants with risk of cardiovascular disease: a Mendelian randomization study.
    Xia J; Guo C; Liu K; Xie Y; Cao H; Peng W; Sun Y; Liu X; Li B; Zhang L
    Lipids Health Dis; 2021 Jun; 20(1):57. PubMed ID: 34074296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein(a) Concentration and Risks of Cardiovascular Disease and Diabetes.
    Gudbjartsson DF; Thorgeirsson G; Sulem P; Helgadottir A; Gylfason A; Saemundsdottir J; Bjornsson E; Norddahl GL; Jonasdottir A; Jonasdottir A; Eggertsson HP; Gretarsdottir S; Thorleifsson G; Indridason OS; Palsson R; Jonasson F; Jonsdottir I; Eyjolfsson GI; Sigurdardottir O; Olafsson I; Danielsen R; Matthiasson SE; Kristmundsdottir S; Halldorsson BV; Hreidarsson AB; Valdimarsson EM; Gudnason T; Benediktsson R; Steinthorsdottir V; Thorsteinsdottir U; Holm H; Stefansson K
    J Am Coll Cardiol; 2019 Dec; 74(24):2982-2994. PubMed ID: 31865966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of low-density lipoprotein cholesterol-related genetic variants with aortic valve calcium and incident aortic stenosis.
    Smith JG; Luk K; Schulz CA; Engert JC; Do R; Hindy G; Rukh G; Dufresne L; Almgren P; Owens DS; Harris TB; Peloso GM; Kerr KF; Wong Q; Smith AV; Budoff MJ; Rotter JI; Cupples LA; Rich S; Kathiresan S; Orho-Melander M; Gudnason V; O'Donnell CJ; Post WS; Thanassoulis G;
    JAMA; 2014 Nov; 312(17):1764-71. PubMed ID: 25344734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Lipoprotein(a) and Calcific Aortic Valve Disease: A Systematic Review and Meta-Analysis.
    Liu Q; Yu Y; Xi R; Li J; Lai R; Wang T; Fan Y; Zhang Z; Xu H; Ju J
    Front Cardiovasc Med; 2022; 9():877140. PubMed ID: 35548407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Frontiers in Lp(a)-Targeted Therapies.
    Borrelli MJ; Youssef A; Boffa MB; Koschinsky ML
    Trends Pharmacol Sci; 2019 Mar; 40(3):212-225. PubMed ID: 30732864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated Lipoprotein(a) Does Not Cause Low-Grade Inflammation Despite Causal Association With Aortic Valve Stenosis and Myocardial Infarction: A Study of 100,578 Individuals from the General Population.
    Langsted A; Varbo A; Kamstrup PR; Nordestgaard BG
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2690-9. PubMed ID: 25938632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidized Phospholipids and Risk of Calcific Aortic Valve Disease: The Copenhagen General Population Study.
    Kamstrup PR; Hung MY; Witztum JL; Tsimikas S; Nordestgaard BG
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1570-1578. PubMed ID: 28572160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein(a) levels are associated with aortic valve calcification in asymptomatic patients with familial hypercholesterolaemia.
    Vongpromek R; Bos S; Ten Kate GJ; Yahya R; Verhoeven AJ; de Feyter PJ; Kronenberg F; Roeters van Lennep JE; Sijbrands EJ; Mulder MT
    J Intern Med; 2015 Aug; 278(2):166-73. PubMed ID: 25487646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology.
    Nordestgaard BG; Langsted A
    J Lipid Res; 2016 Nov; 57(11):1953-1975. PubMed ID: 27677946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.